Fangjian Zhou

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0001-6581-8151

发表论文 258 篇 · 总被引 6059 次 · h-index 35

代表论文

• A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma (2024 · Nature Communications · 被引 22)
• Snai2‐mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB (2024 · Clinical and Translational Medicine · 被引 22)
• Suitability of the MP1000 system for robot-assisted partial nephrectomy: a multicenter randomized controlled noninferiority trial (2024 · International Journal of Surgery · 被引 15)
• Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study. (2025 · Journal of Clinical Oncology · 被引 12)
• SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization (2024 · Molecular Cancer · 被引 10)
• LBA76 Anlotinib in combined with anti-PD-L1 antibody Benmelstobart(TQB2450) versus sunitinib in first-line treatment of advanced renal cell carcinoma (RCC): A randomized, open-label, phase III study (ETER100) (2024 · Annals of Oncology · 被引 8)